Wex launches Health Reimbursement Arrangement for GLP-1 medications

WEX (WEX) announced the launch of a Health Reimbursement Arrangement designed to help employers manage the surging demand and escalating costs of GLP-1 medications . WEX’s specialized solution enables organizations to carve out GLP-1 coverage into a defined-contribution HRA. This puts the power back to the employer amidst shifting economic conditions by helping protect the organization’s core medical plan from unpredictable utilization and premium inflation. By customizing everything from funding to reimbursement rules, employers gain clarity and control over pricing, while ensuring their employees have a reliable safety net for their health journeys.